After 3 great years with a fantastic consortium, the funded @paradise-project.bsky.social project ends with an excellent meeting in @scilifelab.se. Thanks to hosts Peter Nilsson, Elisa Pin and Lotta Prager. The concept of relapse prediction in AAV and the PARADISE consortium live on! #vasculitis

Our last Paradise meeting! 3 years of thinking, learning and try to improve relapse prediction in AAV! Thanks all the consortium and Mark for the opportunity! @paradise-project.bsky.social @thkc.bsky.social

✨ Top 10 most-viewed articles published in ACR Open Rheumatology in 2025 ✨ 3️⃣ Safety of Avacopan for the Treatment of ANCA-Associated Vasculitis: Combined Data From Three Clinical Trials https://doi.org/10.1002/acr2.70001

#KPMP is ending 2025 on a high note with our Q4 2025 Kidney Tissue Atlas Release dropping today 🥳🎉 What are you waiting for? Go check out the explorer, repository AND spatial viewer release highlights! atlas.kpmp.org #Kidney #Atlas #Nephrology #PrecisionMedicine #OpenAccess #Data #PublicData

📣 I am hiring a postdoc! aial.ie/hiring/postd... applications from suitable candidates that are passionate about investigating the use of genAI in public service operations with the aim of keeping governments transparent and accountable are welcome pls share with your networks

A stunning new RPGN #spatiotranscriptomic kidney atlas, including n=32 #ANCA #vasculitis. Bravo to all in the Hamburg team! 🙌 www.nature.com/articles/s41...

Int Society of Nephrology Glomerular Disease fellowships! Our program is not on the small ISN list but can host ISN fellows. We offer glomerular disease clinics, vasculitis clinics, genetics clinics, onconeph clinics and research opportunities. DM if interested! www.theisn.org/in-action/gr...

Our letter to Minister O'Brien — calling for urgent climate, health and biodiversity action. We’ve set out the key priorities we must deliver for a healthier, greener and more resilient future for all. #ClimateAction = #HealthAction

This May, we dedicated our time to raising awareness about vasculitis – and what better way to wrap it up than with a video featuring our incredible patient and public representatives 🎥✨ They’re not just part of the project – they’re the heart of PARADISE. youtube.com/shorts/d4fo8...

A true pleasure to contribute to the 6th #euvas25 course in beautiful Trieste. Great to be back among #vasculitis friends, even if the weather was more like Dublin. @paradise-project.bsky.social

Always an emotional and important day for our students: commencements as trained doctors in the beautiful @tcddublin.bsky.social exam hall.

🎨Beautiful visual abstract by Divya Bajpai #NephJC http://www.nephjc.co...

Next week starts the 6th EUVAS Vasculitis Course in Trieste ! #VAM2025 euvas.it

Registration link: attendee.gotowebinar.com/register/317... #VAM2025

#VAM2025 attendee.gotowebinar.com/register/240...

Only a small group of people genuinely NEED to drive a SUV. For everyone else, it’s time to ban them!

May is almost here !! PARADISE Project is happy to introduce you in the month of Vasculitis Awareness #VAM2025

A true pleasure to host Silvia Vega in TTMI @tcddublin.bsky.social for the last few months. Come back soon! @julianadraibe.bsky.social

TTMI looking gorgeous 🙂 @tcddublin.bsky.social

I wonder are established journals starting to file law suits against predatory journals that use almost exactly the same journal title?

We had a wonderful time of exchange during these 2 days of our Plenary meeting. Many thanks to @uni-freiburg.de and Moritz team for hosting and #EPPerMed to finance #PARADISEProject. @thkc.bsky.social @adaptcentre.bsky.social @julianadraibe.bsky.social @davidselby.bsky.social

A highly appropriate restaurant in #freiburg for the @paradise-project.bsky.social consortium dinner.

Who knew that #frankfurt was so chilled out and beautiful? Looking forward to the annual @paradise-project.bsky.social meeting in Freiburg tomorrow. Lots of #AI in #autoimmune disease 🙂

More (retrospective) data on the use of cyclophosphamide + rituximab in ANCA vasculitis in @kireports.bsky.social VA from @kajareeg.bsky.social www.kireports.org/article/S246... #NephSky

CKD-MBD still undefeated in its ability to generate negative trials! This study sounds like a three-foot putt. How can sevelamer not be better at reducing propensity toward calcification? I don't know but P=0.8.

Unmissable pragmatic clinical approach to #dementia podcasts.apple.com/ie/podcast/t...

We greatly enjoyed hosting Charlotte Velde-Keyzer for the last week, funded by an ERN-RITA mobility award. Hoping to use this as a springboard for an exciting collaboration between @paradise-project.bsky.social and @umcgroningen.bsky.social

🆕📃👀 ANCA negative pauci immune GN ▶️A large series ⬆️ Chronicity and advanced diseased at diagnosis 🫘 limited ⬇️ Relapses, yet poorer prognosis due to advanced disease 😨 @theisn.org #Nephbluesky #Nephsky #Nephrology #NephEd #Medbluesky #Medsky

The vaccine against Shingles helps protect against dementia, results of a natural experiment, adding to prior evidence "implications are profound" New @nature.com www.nature.com/articles/d41... nature.com/articles/s41...

Perspective by Andrew J. Cohen: Is Dialysis Nephrology’s Original Sin? bit.ly/CohenPers25

😱 This is shocking! #Dublin ranked second to last out of 42 cities in @cities_clean's #CityRanking. 🌍 Urgent action is needed for easy access to clean transport.

🌍 Today is #WorldKidneyDay, a reminder to take care of our kidneys! 🩺 850 million people worldwide live with kidney disease—are you at risk? 🔎 Take this one-minute quiz to check your kidney health: kidneyquiz.theisn.org?utm_source=W...

Kicking off @tcddublin.bsky.social #energy week in TTMI - great turnout to hear about how we can contribute to 51% reduction by 2030

#rarediseaseday at Tallaght Hospital. Well done to Emmet Kelly for setting up. @paradise-project.bsky.social

Happy rare disease day! @paradise-project.bsky.social

My PhD lab is hiring a postdoctoral researcher on bobcat ecology! Great location, project, and community. Highly recommend for those working in quantitative ecology: jobs.rwfm.tamu.edu/view-job/?id...

Full house at lab meeting today. What a great team! #vasculitis

A new director for @tcddublin.bsky.social Translational Medicine Institute. Thank you to Aideen Long for 6 years of service which has left the institute in good health.

Rare Disease Day is already next week ! Don't forget to put in your agenda ! #RareDiseaseDay #rarediseaseresearch

Mark Little, our coordinator, presented a very catchy vision of @paradise-project.bsky.social during the #EPPerMed Conference on Personalised Medicine Research. #vasculitis #personalisemedicine

🧵 below @nejm.org paper here: www.nejm.org/doi/full/10.... #ISNWCN LBCT of #obinituzumab in lupus nephritis #SLE

Welcome on Bluesky! @brixsilke.bsky.social @odlerb.bsky.social @thkc.bsky.social @paradise-project.bsky.social. I have included you in the « vasculits lovers » starter pack go.bsky.app/HFADD3c

Nice to hang out with Dr Glassock in Turin - father of GN and #cd163 advocate 🙂

The impressive @lastwalsh.bsky.social with some pearls about trials in rare kidney disease. Thanks for speaking at #irishnephrologysociety winter meeting.

Meanwhile, in Ireland…

The success of the PARADISE #AI tool depends on its technical plausibility and acceptance by both #clinicians and #patients. We’re reaching out to #vasculitis #patients and #clinicians to join us in the Technical Plausibility Testing of an #AI Tool, which will take place throughout 2025.

The main barrier to public transport is not price, but quantity and quality. However, it would be nice to see employers such as the @HSELive subsidise public and active transport instead of providing free parking to staff.

Thank you very much EP PerMed for choosing @paradise-project.bsky.social in your section of ''Success Story''. We are very proud to be part of it 😎and will continue in this way. You can read the article here: www.eppermed.eu/publications...

Visiting Barcelona to examine a PhD thesis and managed to catch up with the @paradise-project.bsky.social crew 😊